NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
Advertisement
NewsRx | Free Trials
Advertisement
----------
------------
NewsRx on Facebook
-----
Press Release Submissions
PR Login
*
*

Women's Health Weekly

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Women's Health Weekly

Learn More

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now



Obstetrics



Researchers' data advance obstetrics research



May 5th, 2005

Data on obstetrics are outlined in reports from the United States, NigerIA and United Kingdom.

Study 1: University of Washington pharmacologists evaluated the pharmacokinetics and pharmacodynamics of the beta blocker atenolol in pregnant and postpartum women.

"Preexisting hypertension complicates 5% of all pregnancies. The objective of this study was to evaluate steady-state atenolol pharmacokinetics and pharmacodynamics (n=17) during the second trimester (2nd T), third trimester (3rd T), and 3 months postpartum," wrote M.F. Hebert and colleagues.

They found that "pregnancy as compared to 3 months postpartum (nonpregnant control)...


Source: Women's Health Weekly (2005-05-05)

NewsRx Passes
Advertisement
More Articles

------------------------
Security by Verisign PR Login